(1)
15. EVALUATING THE SAFETY OF MEASLE VACCINE (MVVAC) MANUFACTURED BY POLYVAC THROUGH PHARMACOVIGILANCE ACTIVITIES. YHCĐ 2023, 64 (2). https://doi.org/10.52163/yhc.v64i2.617.